{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:46:09Z","timestamp":1790736369808,"version":"4.1.0"},"reference-count":120,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>A small library of 79 substituted phenylsulfonamidoalkyl sulfamates, 1b\u201379b, was synthesized starting from arylsulfonyl chlorides and amino alcohols with different numbers of methylene groups between the hydroxyl and amino moieties yielding intermediates 1a\u201379a, followed by the reaction of the latter with sulfamoyl chloride. All compounds were screened for their inhibitory activity on bovine carbonic anhydrase II. Compounds 1a\u201379a showed no inhibition of the enzyme, in contrast to sulfamates 1b\u201379b. Thus, the inhibitory potential of compounds 1b\u201379b towards this enzyme depends on the substituent and the substitution pattern of the phenyl group as well as the length of the spacer. Bulkier substituents in the para position proved to be better for inhibiting CAII than compounds with the same substituent in the meta or ortho position. For many substitution patterns, compounds with shorter spacer lengths were superior to those with long chain spacers. Compounds with shorter spacer lengths performed better than those with longer chain spacers for a variety of substitution patterns. The most active compound held inhibition constant as low as Ki = 0.67 \u03bcM (for 49b) and a tert-butyl substituent in para position and acted as a competitive inhibitor of the enzyme.<\/jats:p>","DOI":"10.3390\/molecules29133015","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:46:56Z","timestamp":1719319616000},"page":"3015","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis and Enzymatic Evaluation of a Small Library of Substituted Phenylsulfonamido-Alkyl Sulfamates towards Carbonic Anhydrase II"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-5651","authenticated-orcid":false,"given":"Toni C.","family":"Denner","sequence":"first","affiliation":[{"name":"Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes, Str. 2, D-06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6540-6357","authenticated-orcid":false,"given":"Niels V.","family":"Heise","sequence":"additional","affiliation":[{"name":"Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes, Str. 2, D-06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-5942","authenticated-orcid":false,"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[{"name":"Natural & Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-290X","authenticated-orcid":false,"given":"Ren\u00e9","family":"Csuk","sequence":"additional","affiliation":[{"name":"Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes, Str. 2, D-06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2166503","DOI":"10.1080\/14756366.2023.2166503","article-title":"Click chemistry approaches for developing carbonic anhydrase inhibitors and their applications","volume":"38","author":"Angeli","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/17460441.2022.2117295","article-title":"Discovery of novel drugs for Chagas disease: Is carbonic anhydrase a target for antiprotozoal drugs","volume":"17","author":"Rodrigues","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00726-021-03063-y","article-title":"Post-translational modifications in tumor-associated carbonic anhydrases","volume":"54","author":"Supuran","year":"2022","journal-title":"Amino Acids"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Giovannuzzi, S., Nikitjuka, A., Pereira Resende, B.R., Smietana, M., Nocentini, A., Supuran, C.T., and Winum, J.-Y. (2024). Boron-containing carbonic anhydrases inhibitors. Bioorg. Chem., 143.","DOI":"10.1016\/j.bioorg.2023.106976"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/13543776.2022.2083502","article-title":"Anticancer carbonic anhydrase inhibitors: A patent and literature update 2018\u20132022","volume":"32","author":"Nerella","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nerella, S.G., Singh, P., Thacker, P.S., Arifuddin, M., and Supuran, C.T. (2023). PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors. Bioorg. Chem., 133.","DOI":"10.1016\/j.bioorg.2023.106399"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Poggetti, V., Salerno, S., Baglini, E., Barresi, E., Da Settimo, F., and Taliani, S. (2022). Carbonic Anhydrase Activators for Neurodegeneration: An Overview. Molecules, 27.","DOI":"10.3390\/molecules27082544"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.semcancer.2022.01.001","article-title":"Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation","volume":"86","author":"Queen","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1080\/14756366.2022.2121393","article-title":"Anti-obesity carbonic anhydrase inhibitors: Challenges and opportunities","volume":"37","author":"Supuran","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Supuran, C.T. (2022). Carbonic Anhydrase Inhibitors from Marine Natural Products. Mar. Drugs, 20.","DOI":"10.3390\/md20110721"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Supuran, C.T. (2023). A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation. Bioorg. Med. Chem. Lett., 93.","DOI":"10.1016\/j.bmcl.2023.129411"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4155\/fmc-2022-0249","article-title":"Latest advances in specific inhibition of tumor-associated carbonic anhydrases","volume":"15","author":"Supuran","year":"2023","journal-title":"Future Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/14728222.2023.2263914","article-title":"An overview of novel antimicrobial carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/13543776.2023.2245971","article-title":"Targeting carbonic anhydrases for the management of hypoxic metastatic tumors","volume":"33","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00018.2021","article-title":"Carbonic anhydrases in metazoan model organisms: Molecules, mechanisms, and physiology","volume":"102","author":"Aspatwar","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lee, S.-K., Boron, W.F., and Occhipinti, R. (2023). Potential Novel Role of Membrane-Associated Carbonic Anhydrases in the Kidney. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044251"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1038\/s41598-023-41012-9","article-title":"Carbonic anhydrase IV in lizard chemical signals","volume":"13","author":"Mangiacotti","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"151834","DOI":"10.1016\/j.acthis.2021.151834","article-title":"Enhanced carbonic anhydrase expression with calcification and fibrosis in bronchial cartilage during COPD","volume":"124","author":"Nava","year":"2022","journal-title":"Acta Histochem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sufian, A.M., Zamanova, S., Shabana, A.M., Kemp, B., Mondal, U.K., Supuran, C.T., and Ilies, M.A. (2023). Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054595"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/1535-7163.MCT-23-0041","article-title":"A carbonic anhydrase IX\/SLC1A5 axis regulates glutamine metabolism dependent ferroptosis in hypoxic tumor cells","volume":"22","author":"Venkateswaran","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1080\/07391102.2021.1898471","article-title":"Microsecond simulation analysis of carbonic anhydrase\u2014II in complex with (+)-cathechin revealed molecular interactions responsible for its amelioration effect on fluoride toxicity","volume":"40","author":"Yadav","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"116434","DOI":"10.1016\/j.ejmech.2024.116434","article-title":"Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: \u03b1-glucosidase and carbonic anhydrase II","volume":"271","author":"Gamal","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Langella, E., Esposito, D., Monti, S.M., Supuran, C.T., De Simone, G., and Alterio, V. (2023). A Combined in Silico and Structural Study Opens New Perspectives on Aliphatic Sulfonamides, a Still Poorly Investigated Class of CA Inhibitors. Biology, 12.","DOI":"10.3390\/biology12020281"},{"key":"ref_24","first-page":"4661","article-title":"Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate","volume":"13","author":"Wang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/138161208783877820","article-title":"Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2174\/156802607780636762","article-title":"Antiobesity carbonic anhydrase inhibitors","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1096\/fasebj.10.4.8647347","article-title":"Differentiation-dependent expression of CA V and the role of carbonic anhydrase isoenzymes in pyruvate carboxylation in adipocytes","volume":"10","author":"Hazen","year":"1996","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bmcl.2004.11.057","article-title":"Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates","volume":"15","author":"Innocenti","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj3100197","article-title":"Role of hepatic carbonic anhydrase in de novo lipogenesis","volume":"310","author":"Lynch","year":"1995","journal-title":"Biochem. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728214.2012.664132","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"17","author":"Supuran","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ghorai, S., Pulya, S., Ghosh, K., Panda, P., Ghosh, B., and Gayen, S. (2020). Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents. Bioorg. Chem., 95.","DOI":"10.1016\/j.bioorg.2019.103557"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF02556255","article-title":"A comparison of the effects of inhibitors of carbonic anhydrase on osteoclastic bone resorption and purified carbonic anhydrase isozyme II","volume":"49","author":"Hall","year":"1991","journal-title":"Calcif. Tissue Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/excr.1998.4071","article-title":"Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+","volume":"242","author":"Lehenkari","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/07853890.2010.486408","article-title":"Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere Vascular Study","volume":"42","author":"Oksala","year":"2010","journal-title":"Ann. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bone.2006.11.028","article-title":"Membrane-bound carbonic anhydrases in osteoclasts","volume":"40","author":"Riihonen","year":"2007","journal-title":"Bone"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.80.9.2752","article-title":"Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification","volume":"80","author":"Sly","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/epi4.12619","article-title":"Acetazolamide: Old drug, new evidence?","volume":"7","author":"Shukralla","year":"2022","journal-title":"Epilepsia Open"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14737175.2015.1066675","article-title":"Acetazolamide for the treatment of idiopathic intracranial hypertension","volume":"15","author":"Supuran","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic anhydrase inhibition and the management of neuropathic pain","volume":"16","author":"Supuran","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3174\/ajnr.A1538","article-title":"The acetazolamide challenge: Techniques and applications in the evaluation of chronic cerebral ischemia","volume":"30","author":"Vagal","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1185\/030079905X65600","article-title":"Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma","volume":"21","author":"Holmstrom","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Mechanisms of disease: Primary open-angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/ICU.0000000000000245","article-title":"Vascular and autonomic dysregulation in primary open-angle glaucoma","volume":"27","author":"Pasquale","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12041-009-0065-3","article-title":"Molecular complexity of primary open angle glaucoma: Current concepts","volume":"88","author":"Ray","year":"2009","journal-title":"J. Genet."},{"key":"ref_46","first-page":"CD003167","article-title":"Medical interventions for primary open angle glaucoma and ocular hypertension","volume":"2007","author":"Vass","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00002512-200320120-00008","article-title":"Brinzolamide: A review of its use in the management of primary open-angle glaucoma and ocular hypertension","volume":"20","author":"Cvetkovic","year":"2003","journal-title":"Drugs Aging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000048311","article-title":"Effects of timolol and dorzolamide on retrobulbar hemodynamics in patients with newly diagnosed primary open-angle glaucoma","volume":"216","author":"Galassi","year":"2002","journal-title":"Ophthalmologica"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9394(01)01158-8","article-title":"Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma","volume":"132","author":"Harris","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","article-title":"Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis","volume":"123","author":"Li","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/bjo.82.7.758","article-title":"Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma","volume":"82","author":"Schmidt","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/112067210901900408","article-title":"Antioxidant status modifications by topical administration of dorzolamide in primary open-angle glaucoma","volume":"19","year":"2009","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: First Approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Huang, L.-K., Kuan, Y.-C., Lin, H.-W., and Hu, C.-J. (2023). Clinical trials of new drugs for Alzheimer disease: A 2020\u20132023 update. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00976-6"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-023-01331-1","article-title":"Lecanemab: More Questions Than Answers!","volume":"44","author":"Kaur","year":"2024","journal-title":"Clin. Drug Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1212\/WNL.0000000000207438","article-title":"Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift","volume":"101","author":"Knopman","year":"2023","journal-title":"Neurology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.17219\/acem\/171379","article-title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer\u2019s disease","volume":"32","author":"Kurkinen","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14737175.2024.2333970","article-title":"Profiling lecanemab as a treatment option for Alzheimer\u2032s disease","volume":"24","author":"Schiller","year":"2024","journal-title":"Expert Rev. Neurother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102203","DOI":"10.1016\/j.arr.2024.102203","article-title":"Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer\u2032s disease: A systematic review and network meta-analysis","volume":"94","author":"Terao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/13543784.2021.1948010","article-title":"Still grasping at straws: Donanemab in Alzheimer\u2019s disease","volume":"30","author":"Doggrell","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cpt.2875","article-title":"Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer\u2032s Disease","volume":"113","author":"Gueorguieva","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/13543776.16.12.1627","article-title":"Carbonic anhydrase inhibitors and activators and their use in therapy","volume":"16","author":"Scozzafava","year":"2006","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4155\/fmc-2021-0222","article-title":"Novel carbonic anhydrase inhibitors","volume":"13","author":"Supuran","year":"2021","journal-title":"Future Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138161208783877956","article-title":"Anticonvulsant sulfonamides\/sulfamates\/sulfamides with carbonic anhydrase inhibitory activity: Drug design and mechanism of action","volume":"14","author":"Thiry","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/13543776.14.9.1273","article-title":"Therapeutic applications of sulfamates","volume":"14","author":"Winum","year":"2004","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/med.20021","article-title":"Sulfamates and their therapeutic potential","volume":"25","author":"Winum","year":"2005","journal-title":"Med. Res. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/13543776.16.1.27","article-title":"The sulfamide motif in the design of enzyme inhibitors","volume":"16","author":"Winum","year":"2006","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmech.2019.06.052","article-title":"Sulfamates in drug design and discovery: Pre-clinical and clinical investigations","volume":"179","author":"Zaraei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_72","first-page":"100162","article-title":"Stereochemistry matters: Inhibition of carbonic anhydrase II by amino acid derived sulfamates depends on their absolute configuration","volume":"11","author":"Denner","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmcl.2005.04.058","article-title":"Carbonic anhydrase: Inhibitors and synthesis of cytosolic\/tumor-associated carbonic anhydrase isoenzymes I, II, and IX with boron-containing sulfonamides, sulfamides and sulfamates. Toward agents for boron neutron capture therapy of hypoxic tumors","volume":"15","author":"Winum","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.saa.2012.08.043","article-title":"The antibacterial activity of some sulfonamides and sulfonyl hydrazones, and 2D-QSAR study of a series of sulfonyl hydrazones","volume":"98","author":"Aslan","year":"2012","journal-title":"Spectrochim. Acta Part A"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B415285A","article-title":"Phospholidines incorporating a \u03b2 N-sulfonylaminoalcohol moiety: First observed selectivity of phosphorus heterocycle aminolysis in the presence of water","volume":"3","author":"Dujols","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"ref_76","first-page":"412","article-title":"N-Arylsulfonamide derivatives of monoethanolamine","volume":"29","author":"Kretov","year":"1959","journal-title":"Zh. Obshch. Khim."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10637-009-9304-y","article-title":"NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth","volume":"28","author":"Papaioannou","year":"2010","journal-title":"Investig. New Drugs"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/prac.19321350707","article-title":"Reaction of primary and secondary amino alcohols and amino phenols with arylsulfonyl chlorides","volume":"135","author":"Slotta","year":"1932","journal-title":"J. Prakt. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1021\/jacs.9b06050","article-title":"New Catalytic Asymmetric Formation of Oxygen Heterocycles Bearing Nucleoside Bases at the Anomeric Carbon","volume":"141","author":"Trost","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1039\/D2QO00390B","article-title":"Accessing chiral 2,2-disubstituted morpholines via organocatalytic enantioselective chlorocycloetherification","volume":"9","author":"Zhong","year":"2022","journal-title":"Org. Chem. Front."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/jm00327a017","article-title":"Some cardiovascular effects of a series of aryloxyalkylamines. I","volume":"8","author":"Augstein","year":"1965","journal-title":"J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1016\/S0040-4039(03)01666-6","article-title":"Metal oxide in aqueous organic solution promoted chemoselective N-sulfonylation of hydrophilic amino alcohols","volume":"44","author":"Kang","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1139\/v95-260","article-title":"Synthesis of cyclic and acyclic imides, sulfonimides, and N-carbobenzyloxyamides by ketene trapping","volume":"73","author":"MaGee","year":"1995","journal-title":"Can. J. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/S0040-4039(97)00696-5","article-title":"An efficient protocol for the selective reduction of benzenesulfonyllactam to benzenesulfonyl cyclic amine","volume":"38","author":"Hosaka","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1021\/acs.orglett.7b01346","article-title":"Enantioselective Iridium-Catalyzed Allylic Cyclizations","volume":"19","author":"Schafroth","year":"2017","journal-title":"Org. Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"14272","DOI":"10.1002\/chem.201002606","article-title":"Gold-Catalyzed Direct Activation of Allylic Alcohols in the Stereoselective Synthesis of Functionalized 2-Vinyl-Morpholines","volume":"16","author":"Bandini","year":"2010","journal-title":"Chem.\u2014Eur. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"o980","DOI":"10.1107\/S1600536807003698","article-title":"2-[N-(Prop-2-ynyl)-N-tosylamino]ethanol","volume":"63","author":"Chinnakali","year":"2007","journal-title":"Acta Crystallogr. Sect. E Struct. Rep. Online"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/ol102956x","article-title":"2,2-Difunctionalization of Alkenes via Pd(II)-Catalyzed Aza-Wacker Reactions","volume":"13","author":"Elliott","year":"2011","journal-title":"Org. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/ja078163b","article-title":"Copper-Catalyzed 1,2-Double Amination of 1-Halo-1-alkynes. Concise Synthesis of Protected Tetrahydropyrazines and Related Heterocyclic Compounds","volume":"130","author":"Fukudome","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"10325","DOI":"10.1021\/jo201975b","article-title":"Stereoselective Synthesis of C-Substituted Morpholine Derivatives using Reductive Etherification Reaction: Total Synthesis of Chelonin C","volume":"76","author":"Gharpure","year":"2011","journal-title":"J. Org. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apcata.2009.01.042","article-title":"Catalytic activity of silica gel in the synthesis of sulfonamides under mild and solvent-free conditions","volume":"358","author":"Jafarpour","year":"2009","journal-title":"Appl. Catal. A"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.1021\/jacs.7b06794","article-title":"Palladium-Catalyzed Carbocyclizations of Unactivated Alkyl Bromides with Alkenes Involving Auto-tandem Catalysis","volume":"139","author":"Venning","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1021\/ol061649x","article-title":"New Aspects of Catalytic Intramolecular C-H Amination: Unexpected Formation of a Seven-Membered Ring in Nitrogen-Containing Systems","volume":"8","author":"Toumieux","year":"2006","journal-title":"Org. Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1021\/ja00323a030","article-title":"Total synthesis of anhydrocannabisativene","volume":"106","author":"Bailey","year":"1984","journal-title":"J. Am. Chem. Soc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1021\/ja4047312","article-title":"Enantioselective Intramolecular Aldehyde \u03b1-Alkylation with Simple Olefins: Direct Access to Homo-Ene Products","volume":"135","author":"Comito","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/157017811794557886","article-title":"Synthesis, stereochemistry and ring-chain tautomerism of some new bis(1,3-perhydrooxazin-2-yl)benzene derivatives","volume":"8","author":"Nan","year":"2011","journal-title":"Lett. Org. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1038\/s41467-022-31920-1","article-title":"Divergent synthesis of benzazepines and bridged polycycloalkanones via dearomative rearrangement","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/jo01060a034","article-title":"Potential anticancer agents. VI. N-(3-Hydroxypropyl)benzaldimine and related compounds","volume":"26","author":"Vaughan","year":"1961","journal-title":"J. Org. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/ol0266929","article-title":"Synthesis of 3,4-Disubstituted Piperidines by Carbonyl Ene and Prins Cyclizations: A Switch in Diastereoselectivity between Lewis and Bronsted Acid Catalysts","volume":"4","author":"Williams","year":"2002","journal-title":"Org. Lett."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1016\/S0040-4039(00)76177-6","article-title":"Mitsunobu reactions of N-alkyl and N-acyl sulfonamides\u2014An efficient route to protected amines","volume":"30","author":"Henry","year":"1989","journal-title":"Tetrahedron Lett."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1002\/chem.201202080","article-title":"Biomimetic Aerobic Oxidation of Amino Alcohols to Lactams","volume":"18","author":"Babu","year":"2012","journal-title":"Chem.\u2014Eur. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1039\/p19780001682","article-title":"Reactions of relevance to the chemistry of aminoglycoside antibiotics. Part 9. New reagents for amination of the ethylenic linkage","volume":"1","author":"Barton","year":"1978","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ejoc.202000026","article-title":"Synthesis and Structural Elucidation of 1,2-Disubstituted 3-Fluoropiperidines","volume":"2020","author":"Fischer","year":"2020","journal-title":"Eur. J. Org. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/ol070537i","article-title":"\u03b1-Amidation of Cyclic Ethers Catalyzed by Simple Copper Salt and a Mild and Efficient Preparation Method for \u03b1,\u03c0-Amino Alcohols","volume":"9","author":"He","year":"2007","journal-title":"Org. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1021\/acs.orglett.9b02144","article-title":"p-Methylbenzyl Group: Oxidative Removal and Orthogonal Alcohol Deprotection","volume":"21","author":"Ikeuchi","year":"2019","journal-title":"Org. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.tet.2012.03.097","article-title":"Mg(ClO4)2-Catalyzed intramolecular allylic amination: Application to the total synthesis of demethoxyfumitremorgin C","volume":"68","author":"Jiang","year":"2012","journal-title":"Tetrahedron"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1248\/cpb.39.1112","article-title":"Synthesis of carbocyclic nucleosides from 2-azabicyclo[2.2.1]hept-5-en-3-ones: Sodium borohydride mediated carbon-nitrogen bond cleavage of five- and six-membered lactams","volume":"39","author":"Katagiri","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Zhou, B., Zhang, Y.-Q., Zhang, K., Yang, M.-Y., Chen, Y.-B., Li, Y., Peng, Q., Zhu, S.-F., Zhou, Q.-L., and Ye, L.-W. (2019). Stereoselective synthesis of medium lactams enabled by metal-free hydroalkoxylation\/stereospecific [1,3]-rearrangement. Nat. Commun., 10.","DOI":"10.1038\/s41467-019-11245-2"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/asia.201800759","article-title":"Ruthenium-Pincer-Catalyzed Hydrogenation of Lactams to Amino Alcohols","volume":"13","author":"Chen","year":"2018","journal-title":"Chem.\u2014Asian J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1039\/C6OB01813K","article-title":"Metal-free one-pot \u03b1-carboxylation of primary alcohols","volume":"14","author":"Kraakman","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/acs.joc.1c00752","article-title":"Palladium-Catalyzed Ring-Closing Reaction for the Synthesis of Saturated N-Heterocycles with Aminodienes and N,O-Acetals","volume":"86","author":"Yu","year":"2021","journal-title":"J. Org. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1021\/acscatal.1c00731","article-title":"Nickel\/Photoredox Dual Catalytic Cross-Coupling of Alkyl and Amidyl Radicals to Construct C(sp3)-N Bonds","volume":"11","author":"Zhou","year":"2021","journal-title":"ACS Catal."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1039\/C5CC00321K","article-title":"A novel rhodium-catalyzed domino-hydroformylation-reaction for the synthesis of sulphonamides","volume":"51","author":"Dong","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/ejoc.202100404","article-title":"Phosphine-Catalyzed Synthesis of Chiral N-Heterocycles through (Asymmetric) P(III)\/P(V) Redox Cycling","volume":"2021","author":"Lorton","year":"2021","journal-title":"Eur. J. Org. Chem."},{"key":"ref_115","first-page":"65","article-title":"Behavior of saccharin, N-methylsaccharin and N-ethanolsaccharin on nickel cathodes and during nickel electrodeposition","volume":"1","author":"Butkiene","year":"1996","journal-title":"Chemija"},{"key":"ref_116","first-page":"615","article-title":"Preparation of N-(\u03b2-hydroxyethyl)arenesulfonamides with ethylene oxide","volume":"25","author":"Kretov","year":"1959","journal-title":"Ukr. Khem. Zh."},{"key":"ref_117","first-page":"1360","article-title":"The behavior of saccharin and its N-derivatives during electrodeposition of the iron metals from acidic electrolytes","volume":"32","author":"Motskute","year":"1996","journal-title":"Russ. J. Electrochem. (Transl. Elektrokhimiya)"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1039\/D3SC01880F","article-title":"Organocatalytic intramolecular (4 + 2) annulation of enals with ynamides: Atroposelective synthesis of axially chiral 7-aryl indolines","volume":"14","author":"Zhang","year":"2023","journal-title":"Chem. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"18331","DOI":"10.1021\/jacs.1c09484","article-title":"Phosphine\/Photoredox Catalyzed Anti-Markovnikov Hydroamination of Olefins with Primary Sulfonamides via \u03b1-Scission from Phosphoranyl Radicals","volume":"143","author":"Chinn","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"18405","DOI":"10.1021\/jacs.9b10316","article-title":"Copper-Catalyzed, N-Directed Csp3-H Trifluoromethylthiolation (-SCF3) and Trifluoromethylselenation (-SeCF3)","volume":"141","author":"Modak","year":"2019","journal-title":"J. Am. Chem. Soc."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/13\/3015\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:04:21Z","timestamp":1760108661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/13\/3015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":120,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["molecules29133015"],"URL":"https:\/\/doi.org\/10.3390\/molecules29133015","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}